MyoPro-Assisted Therapy for Stroke
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but if you are taking medications that lower the threshold for seizures, you may not be eligible to participate.
What data supports the effectiveness of the treatment MyoPro-Assisted Therapy for Stroke?
Research suggests that robot-assisted movement training, which involves both patient effort and robotic assistance, can improve arm movement after a stroke. Although the specific role of robotic forces is still unclear, studies indicate that combining movement practice with robotic assistance may offer additional benefits.12345
Is MyoPro-Assisted Therapy for Stroke safe for humans?
How is MyoPro-Assisted Therapy for Stroke different from other treatments for stroke?
MyoPro-Assisted Therapy for Stroke is unique because it uses a myoelectric orthosis, which detects the user's muscle signals to assist in movement, allowing patients to actively participate in their rehabilitation. This approach contrasts with traditional therapies that may rely more on passive movement, as it encourages patients to use their own muscle strength, potentially leading to better recovery outcomes.19101112
What is the purpose of this trial?
This study will evaluate the effects of combining motor learning-based therapy with use of the MyoPro , a wearable exoskeletal myoelectrically controlled orthotic device. MyoPro uses electromyographic (EMG) signals from the weak muscles to assist movement of the user's affected arm. The primary objective of this randomized controlled trial is to study the efficacy of using MyoPro in motor learning-based therapy for individuals with chronic stroke (\>6 months post) with severe upper limb motor deficits (Fugl-Meyer for Upper Limb score less than 30) compared with a similar dose of motor learning-based therapy alone. The secondary objectives are to evaluate neuroplasticity mechanisms, identify biomarkers of greater response to the intervention, and explore cost-effectiveness.
Research Team
Svetlana Pundik, MD
Principal Investigator
Louis Stokes VA Medical Center, Cleveland, OH
Eligibility Criteria
Adults aged 18-89 with severe arm weakness from a stroke that happened at least 6 months ago can join. They must be able to move their shoulder a bit, wear the MyoPro device, and produce muscle signals it can read. People with metal in their skull, pacemakers, or conditions like seizures or claustrophobia that make MRI scans unsafe cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 9 weeks of in-clinic training with MyoPro and motor learning-based therapy, followed by 9 weeks of home practice
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Motor Learning-Based Therapy
- MyoPro
Motor Learning-Based Therapy is already approved in United States, European Union for the following indications:
- Severe chronic arm motor deficits due to stroke
- Neuromuscular rehabilitation for conditions such as stroke, spinal cord injury, and brachial plexus injury
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor